iTeos Therapeutics, Inc. (NASDAQ:ITOS) Director Sells $388,004.05 in Stock
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) Director David Hallal sold 38,227 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $10.15, for a total transaction of $388,004.05. The sale was disclosed in a filing with the Securities & Exchange Commission, […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) Director David Hallal sold 38,227 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $10.15, for a total transaction of $388,004.05. The sale was disclosed in a filing with the Securities & Exchange Commission, […]
